FOLR1 and ovarian cancer: D. Powell (University of Pennsylvania, USA) already presented in the previous edition of this meeting a FRα CAR T cells able to efficiently eliminate aggressive ovarian cancer xenografts in a murine subcutaneous tumor model [55].